Benjamin Edwards Inc. Acquires 23,173 Shares of Tempus AI, Inc. (NASDAQ:TEM)

Benjamin Edwards Inc. increased its holdings in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 180.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 35,988 shares of the company's stock after buying an additional 23,173 shares during the period. Benjamin Edwards Inc.'s holdings in Tempus AI were worth $1,215,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently bought and sold shares of the company. ARK Investment Management LLC grew its holdings in Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company's stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its stake in Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company's stock worth $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Nikko Asset Management Americas Inc. increased its position in Tempus AI by 166.0% during the 4th quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company's stock valued at $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. raised its stake in Tempus AI by 240.5% in the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after buying an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its holdings in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock worth $55,836,000 after acquiring an additional 1,651,996 shares in the last quarter. Hedge funds and other institutional investors own 24.22% of the company's stock.

Insider Activity

In related news, CEO Eric P. Lefkofsky sold 80,388 shares of the stock in a transaction that occurred on Friday, February 7th. The stock was sold at an average price of $67.53, for a total value of $5,428,601.64. Following the completion of the transaction, the chief executive officer now directly owns 5,293,005 shares in the company, valued at approximately $357,436,627.65. This represents a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Nadja West sold 809 shares of Tempus AI stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $51.11, for a total value of $41,347.99. Following the completion of the sale, the director now owns 37,705 shares in the company, valued at $1,927,102.55. This represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 4,297,949 shares of company stock valued at $255,591,733. 27.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

TEM has been the subject of a number of recent analyst reports. Wolfe Research cut shares of Tempus AI from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, February 26th. BTIG Research started coverage on shares of Tempus AI in a report on Monday, April 21st. They set a "buy" rating and a $60.00 price objective on the stock. TD Cowen reissued a "buy" rating and issued a $74.00 target price (up from $58.00) on shares of Tempus AI in a research report on Wednesday, February 5th. Guggenheim reiterated a "buy" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Finally, William Blair restated a "market perform" rating on shares of Tempus AI in a research note on Tuesday, February 25th. Six analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Tempus AI presently has a consensus rating of "Moderate Buy" and an average target price of $61.08.

Tempus AI Stock Performance

Shares of NASDAQ TEM opened at $58.76 on Thursday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The firm's 50 day simple moving average is $47.93 and its 200-day simple moving average is $50.76. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45.

Tempus AI (NASDAQ:TEM - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating the consensus estimate of ($0.27) by $0.03. The business had revenue of $255.74 million during the quarter, compared to analysts' expectations of $248.13 million. The business's revenue was up 75.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.